Most diabetic neuropathy combinations on the market stop at three ingredients — Methylcobalamin, Benfotiamine and Alpha Lipoic Acid. ERIEVO covers that same neuropathy pathway and adds two ingredients most competing combinations skip: Chromium Polynicotinate and Myo-Inositol, both involved in insulin signaling rather than nerve repair. That makes it a dual-action formulation rather than a neuropathy-only one.
At a Glance
7-ingredient film-coated tablet
Covers nerve health and metabolic/insulin-sensitivity pathways together
High-dose Methylcobalamin at 1500mcg
Benfotiamine and Alpha Lipoic Acid for oxidative and glycation-related nerve stress
Composition
Each film-coated tablet contains:
Methylcobalamin IP — 1500 mcg
Benfotiamine — 200 mg
Alpha Lipoic Acid USP — 200 mg
Folic Acid IP — 1.5 mg
Chromium Polynicotinate USP — 200 mcg
Myo-Inositol BP — 100 mg
Pyridoxine Hydrochloride IP — 3 mg
Why This Combination
Diabetic peripheral neuropathy has more than one contributing mechanism, and this formulation is built to address several of them rather than just one. Methylcobalamin, Folic Acid and Pyridoxine work through the B-vitamin/homocysteine pathway that supports nerve myelin and regeneration. Benfotiamine is a fat-soluble form of B1 with better bioavailability than standard thiamine, and it helps reduce the formation of advanced glycation end-products — a known contributor to nerve damage in chronically elevated blood sugar. Alpha Lipoic Acid adds antioxidant support, counteracting the oxidative stress that accompanies diabetic neuropathy and is linked to improved nerve conduction in clinical use.
Chromium Polynicotinate and Myo-Inositol work on a different axis entirely — both are involved in supporting insulin receptor signaling and glucose metabolism. Including them means the formulation isn't only managing nerve symptoms after the fact, it's also addressing part of the metabolic picture that contributes to those symptoms in the first place.
Indications / Areas of Use
- Diabetic peripheral neuropathy and related nerve symptoms
- Vitamin B12, B6 and folate deficiency states
- Nutritional support for patients with insulin resistance or metabolic syndrome, as advised by the physician
- General fatigue and nerve-related discomfort linked to micronutrient deficiency
Who Typically Prescribes ERIEVO
Diabetologists and Endocrinologists prescribe it for patients with diabetic neuropathy alongside metabolic concerns. Neurologists use it for peripheral neuropathy management more broadly, and General Physicians prescribe it for micronutrient deficiency and general nerve-related fatigue.
Dosage & Administration
As prescribed by a Registered Medical Practitioner. Typically one tablet daily, or as directed. Not for self-medication.
Safety Information
For use under medical supervision. Not recommended in known hypersensitivity to any listed ingredient. Store below 25°C, protect from light and moisture. Keep out of reach of children.
Patient Counselling Points
- Take at the same time daily for consistent results
- Continue for the full duration advised, even if nerve symptoms improve early
- Report any worsening of numbness, tingling, or new symptoms to the physician
- Inform the physician of all other supplements or medications being taken concurrently
Why ERIEVO from Eridanus Healthcare
ERIEVO® is manufactured at a WHO-GMP certified facility, with all seven actives dosed at pharmacopoeial-grade strength. Its dual-pathway composition — nerve support plus metabolic support — gives franchise partners a genuine point of difference to lead with in front of diabetologists and endocrinologists, rather than competing purely on price against simpler 3-ingredient combinations. It's open for PCD Pharma Franchise across India.
Frequently Asked Questions
What is ERIEVO used for?
ERIEVO is a 7-ingredient combination used for diabetic peripheral neuropathy, B12/B6/folate deficiency, and nutritional support relevant to insulin resistance, as prescribed by a registered medical practitioner.
How is ERIEVO different from standard neuropathy tablets?
Most neuropathy combinations use just Methylcobalamin, Benfotiamine and Alpha Lipoic Acid. ERIEVO adds Chromium Polynicotinate and Myo-Inositol, which support insulin signaling rather than nerve repair directly — addressing the metabolic side of diabetic neuropathy alongside the nerve side.
Is ERIEVO meant to manage PCOS?
The Myo-Inositol dose in ERIEVO is intended for general metabolic and insulin-sensitivity support, not the higher therapeutic doses used specifically in PCOS management.
Is ERIEVO available for PCD Pharma Franchise?
Yes. ERIEVO is open for PCD Pharma Franchise across India under Eridanus Healthcare.
Disclaimer: This information is provided for general knowledge purposes only and is not a substitute for professional medical advice. Please consult a registered medical practitioner before taking this or any medication.